Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Malignant Melanoma

  Free Subscription


21.09.2020

2 Ann Surg Oncol
1 Cancer
2 Clin Cancer Res
1 Cutis
2 J Am Acad Dermatol
1 J Biol Chem
1 J Invest Dermatol
1 J Surg Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Surg Oncol

  1. CARR MJ, Kroon HM, Zager JS
    ASO Author Reflections: Return to Isolated Limb Infusion for In-Transit Melanoma.
    Ann Surg Oncol. 2020 Sep 11. pii: 10.1245/s10434-020-09113.
    PubMed        

  2. CARR MJ, Sun J, Kroon HM, Miura JT, et al
    Oncologic Outcomes After Isolated Limb Infusion for Advanced Melanoma: An International Comparison of the Procedure and Outcomes Between the United States and Australia.
    Ann Surg Oncol. 2020 Sep 11. pii: 10.1245/s10434-020-09051.
    PubMed         Abstract available


    Cancer

  3. QIAN JM, Martin AM, Martin K, Hammoudeh L, et al
    Response rate and local recurrence after concurrent immune checkpoint therapy and radiotherapy for non-small cell lung cancer and melanoma brain metastases.
    Cancer. 2020 Sep 14. doi: 10.1002/cncr.33196.
    PubMed         Abstract available


    Clin Cancer Res

  4. TANG B, Chi Z, Chen Y, Liu X, et al
    Correction: Safety, Efficacy, and Biomarker Analysis of Toripalimab in Previously Treated Advanced Melanoma: Results of the POLARIS-01 Multicenter Phase II Trial.
    Clin Cancer Res. 2020;26:5048.
    PubMed        

  5. TRUONG A, Yoo JH, Scherzer M, Sanchez JMS, et al
    Chloroquine sensitizes GNAQ/11-mutated melanoma to MEK1/2 inhibition.
    Clin Cancer Res. 2020 Sep 15. pii: 1078-0432.CCR-20-1675.
    PubMed         Abstract available


    Cutis

  6. CRUZVAL-O'REILLY E, Lugo-Somolinos A
    Melanoma in hispanics: we may have it all wrong.
    Cutis. 2020;106:28-30.
    PubMed        


    J Am Acad Dermatol

  7. LYTVYN Y, Mufti A, Sachdeva M, Maliyar K, et al
    Stevens Johnson Syndrome and Toxic Epidermal Necrolysis Reactions to BRAF and MEK Inhibitors in Patients with Melanoma: A Systematic Review.
    J Am Acad Dermatol. 2020 Sep 11. pii: S0190-9622(20)32613.
    PubMed        

  8. MONTAUDIE H, Le Duff F, Butori C, Hofman V, et al
    Ingenol mebutate to treat lentigo maligna of the head (face and scalp): A prospective, multicenter, single-arm phase 2 trial indicates no benefit.
    J Am Acad Dermatol. 2020;82:731-733.
    PubMed        


    J Biol Chem

  9. MONTAGNANI V, Maresca L, Apollo A, Pepe S, et al
    E3 ubiquitin ligase PARK2, an inhibitor of melanoma cell growth, is repressed by the oncogenic ERK1/2-ELK1 transcriptional axis.
    J Biol Chem. 2020 Sep 16. pii: RA120.014615. doi: 10.1074/jbc.RA120.014615.
    PubMed         Abstract available


    J Invest Dermatol

  10. OLSEN CM, Pandeya N, Dusingize JC, Thompson BS, et al
    Can people correctly assess their future risk of melanoma?
    J Invest Dermatol. 2020 Sep 11. pii: S0022-202X(20)31964.
    PubMed        


    J Surg Oncol

  11. AIKEN TJ, Stahl CC, Schwartz PB, Barrett J, et al
    Sentinel lymph node biopsy is associated with increased cost in higher risk thin melanoma.
    J Surg Oncol. 2020 Sep 16. doi: 10.1002/jso.26225.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: